ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ADMP Adamis Pharmaceuticals Corporation

0.775063
0.00 (0.00%)
25 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Adamis Pharmaceuticals Corporation ADMP NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.775063 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.775063 0.775063
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/9/202315:50EDGAR2Form 8-K - Current report
07/9/202311:00GLOBEAdamis Pharmaceuticals Changes Name to DMK Pharmaceuticals..
01/9/202315:45EDGAR2Form 8-K - Current report
29/8/202315:30EDGAR2Form 8-K - Current report
21/8/202316:20EDGAR2Form 8-K - Current report
21/8/202308:15GLOBEAdamis Pharmaceuticals Reports Second Quarter 2023 Financial..
14/8/202315:38EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
10/8/202315:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/8/202312:43GLOBEAdamis Pharmaceuticals Announces Closing of $8.0 Million..
03/8/202315:59EDGAR2Form 8-K - Current report
03/8/202315:55EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
02/8/202307:30GLOBEAdamis Pharmaceuticals Announces Pricing of $8.0 Million..
01/8/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
31/7/202316:13EDGAR2Form 8-K - Current report
28/7/202316:01EDGAR2Form 8-K - Current report
28/7/202315:58EDGAR2Form S-1/A - General form for registration of securities..
28/7/202307:30GLOBEAdamis Pharmaceuticals to Fund ZIMHI® Clinical Study with..
27/7/202305:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
26/7/202320:17EDGAR2Form S-1/A - General form for registration of securities..
24/7/202315:20EDGAR2Form 8-K - Current report
24/7/202315:15EDGAR2Form 8-K - Current report
13/7/202315:37EDGAR2Form S-1 - General form for registration of securities under..
26/6/202306:30GLOBEAdamis Pharmaceuticals Announces NIH Grant Funding for the..
22/6/202306:30GLOBEAdamis Pharmaceuticals Participated in White House Meeting..
25/5/202315:26GLOBEAdamis Pharmaceuticals Announces Closing of the Merger with..
19/5/202311:00GLOBEAdamis Pharmaceuticals Announces Reverse Stock Split
15/5/202315:47GLOBEAdamis Pharmaceuticals Reports First Quarter 2023 Financial..
08/5/202315:05GLOBEAdamis Pharmaceuticals Schedules First Quarter 2023..

Su Consulta Reciente

Delayed Upgrade Clock